Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|September 9, 2024
Cellular stress increases DRIP production and MHC Class I antigen presentationNatalie Pach, Michael Basler
Frontiers in Immunology|August 18, 2025
The ubiquitin-like modifier FAT10 is not essential for MHC-I antigen presentationNatalie Pach, Sarah Ochs, Jinjing Cao, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 19, 2013
Using protease inhibitors in antigen presentation assaysMichael Basler, Marcus Groettrup
Methods in Molecular Biology (Clifton, N.J.)|February 22, 2012
Immunoproteasome-specific inhibitors and their applicationMichael Basler, Marcus Groettrup
Drugs & Aging|March 17, 2007
Advances in prostate cancer immunotherapiesMichael Basler, Marcus Groettrup
Cells|November 27, 2021
On the Role of the Immunoproteasome in Protein HomeostasisMichael Basler, Marcus Groettrup
Genes and Immunity|August 26, 2020
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacyMichael Basler, Marcus Groettrup
Pharmaceutics|February 25, 2023
PLGA Particles in ImmunotherapyDennis Horvath, Michael Basler
European Journal of Immunology|March 16, 2007
No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopesMichael Basler, Marcus Groettrup
Methods in Molecular Biology (Clifton, N.J.)|June 1, 2019
Testing the Impact of Protease Inhibitors in Antigen Presentation AssaysMichael Basler, Marcus Groettrup
Pageof 8